1. Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study. Issue 1 (18th March 2017) Authors: Cutolo, Maurizio; Hopp, Michael; Liebscher, Stefan; Dasgupta, Bhaskar; Buttgereit, Frank Journal: RMD open Issue: Volume 3:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PANDA: Prolonged release oxycodone/naloxone (OXN PR) for severe Parkinson's disease (PD)-related pain. (January 2016) Authors: Chaudhuri, K. Ray; Martinez-Martin, Pablo; Rascol, Olivier; Lomax, Mark; DeCesare, Julia; Hopp, Michael Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prolonged-release oxycodone–naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. Issue 12 (December 2015) Authors: Trenkwalder, Claudia; Chaudhuri, K Ray; Martinez-Martin, Pablo; Rascol, Olivier; Ehret, Reinhard; Vališ, Martin; Sátori, Maria; Krygowska-Wajs, Anna; Marti, Maria J; Reimer, Karen; Oksche, Alexander; Lomax, Mark; DeCesare, Julia; Hopp, Michael Journal: Lancet neurology Issue: Volume 14:Issue 12(2015:Dec.) Page Start: 1161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗